Eli Lilly | LLY - Trade Debtors

Stock Price
938.62
Daily Change
-15.90 -1.67%
Monthly
-7.79%
Yearly
14.71%
Q2 Forecast
851.89

Eli Lilly reported $19.46B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Abbott USD 10.4B 166M Sep/2025
ALKERMES USD 334.02M 21.08M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Baxter International USD 2.01B 231M Dec/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
J&J USD 17.61B 235M Sep/2025
Medtronic USD 6.36B 30M Dec/2025
Merck USD 12.12B 596M Sep/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Perrigo USD 612.8M 31.6M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 190.46M 8.54M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Sanofi EUR 397M 186.13M Dec/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Zoetis USD 1.59B 49M Dec/2025